---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-011712"
form_type: "8-K"
ticker: null
cik: "0001279695"
company_name: "UNIVERSAL BIOSENSORS INC"
filed_at: "2024-04-11T23:59:59+00:00"
generated_at: "2026-06-03T23:51:15.920122+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Universal Biosensors launches A$10M underwritten entitlement offer at A$0.15/CDI with attaching options

## Summary
- Fully underwritten pro-rata non-renounceable offer of 1 new CDI per 3.47 existing at A$0.15, plus 1 option per CDI (A$0.20 exercise, 3-year term).
- Underwriter receives 13.85M options as fee; gross proceeds ~A$10M to fund growth, product development, operating losses, and Xprecia Prime sales after FDA approval.
- Stockholders approved increase in authorized common shares from 300M to 750M at April 10 special meeting.
- All four stockholder proposals passed: Underwriter Options, Placement CDIs, Placement Options, and Authorized Shares increase.
- Offer restricted to Australia/New Zealand resident holders; U.S. persons and other ineligible holders excluded.

## SEC filing metadata
- accession: 0001437749-24-011712
- form_type: 8-K
- cik: 0001279695
- company_name: UNIVERSAL BIOSENSORS INC
- filed_at: 2024-04-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/ubi20240411_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-011712
- JSON: https://secwatch.observer/filing/0001437749-24-011712.json
- Plain text: https://secwatch.observer/filing/0001437749-24-011712.txt

## Key facts
- Governance Changes
  UNIVERSAL BIOSENSORS INC: Increased authorized shares of common stock from 300,000,000 to 750,000,000 (effective 2024-04-10).
  - Change: charter amendment
  - Effective: 2024-04-10
  source text: the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of the Company’s common stock from 300,000,000 shares to 750,000,000 shares.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm
- Material Agreements
  UNIVERSAL BIOSENSORS INC entered into Underwriting Agreement with an underwriter valued at approximately A$10 million (effective 2024-04-11).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: an underwriter
  - Value: approximately A$10 million
  - Effective: 2024-04-11
  source text: On April 11, 2024, Universal Biosensors, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with an underwriter named in the Underwriting Agreement (the “Underwriter”), whereby the Company agreed to issue: (i) up to 66,666,667 shares of its common stock in the form of CHESS Depositary Interests (“CDIs”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm
- Shareholder Votes
  UNIVERSAL BIOSENSORS INC shareholders approved Authorized Shares Proposal at the 2024-04-10 meeting.
  - Outcome: passed
  - Meeting: 2024-04-10
  source text: Proposal 4 Authorized Shares Proposal 108,416,353 2,323,110 1,307,106 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm
- Shareholder Votes
  UNIVERSAL BIOSENSORS INC shareholders approved Underwriter Options Proposal at the 2024-04-10 meeting.
  - Outcome: passed
  - Meeting: 2024-04-10
  source text: Proposal 1 Underwriter Options Proposal 52,880,699 2,603,610 55,808,640 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm
- Shareholder Votes
  UNIVERSAL BIOSENSORS INC shareholders approved Placement CDIs Ratification Proposal at the 2024-04-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-04-10
  source text: Proposal 2 Placement CDIs Ratification Proposal 103,092,909 7,643,449 1,310,211 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm
- Shareholder Votes
  UNIVERSAL BIOSENSORS INC shareholders approved Placement Options Proposal at the 2024-04-10 meeting.
  - Outcome: passed
  - Meeting: 2024-04-10
  source text: Proposal 3 Placement Options Proposal 102,831,014 7,908,449 1,307,106 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279695/000143774924011712/0001437749-24-011712-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.